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INTRODUCTION
Beh et’ s disease is a chronic systemic inflammatory disease
involving mucous membranes, skin, eyes, gastrointestinal
tract, joints, vessels, and neurologic systems (1). It occurs
endemically in the Middle East and the Mediterranean re-
gions. It is also distributed in the Central and East Asian
countries including Korea (2), Japan (3), and China (4). The
patients with Beh et’ s disease have been increasing in
Korea and the epidemiological and clinical features of the
disease have been reported by some institutes (2). However,
the nationwide studies have not been performed yet.
The Korean Study Group for Beh et’ s disease was found-
ed in 1999 and the first nationwide multicenter survey on
epidemiological and clinical features of Beh et’ s disease in
Korea was performed.
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Epidemiologic and Clinical Survey of Behcet's Disease in Korea: 
the First Multicenter Study
The prevalence of Behcet’ s disease is the highest in the East Asian and the Medi-
terranean countries. Behcet’ s disease is also distributed in the Asian countries,
but the nationwide survey has not been performed in Korea yet. The Korean
Study Group for Behcet’ s Disease, founded in 1999, conducted a multicenter,
retrospective survey on epidemiologic and clinical features of the patients with
Behcet’ s disease from 20 hospitals around the nation from 1997 to 1999. Of 3,497
patients, 1,527 were classified into complete or incomplete type of Behcet’ s dis-
ease according to the revised Shimizu’ s classification. The sex ratio was 1:1.75
with the female predominance. Geographical distribution showed the highest fre-
quency in Seoul (38.5%). Clinically, 98.8% had oral ulcers, 83.2% had genital
ulcers, 84.3% had skin lesions and 50.9% had ocular lesions. As for the minor
clinical manifestations, articular symptoms were the most frequent. The pathergy
test showed positive in 15.4% of patients and revealed a higher positive rate in
males (20.2%) than in females (12.7%). In conclusion, we performed the first
multicenter study on Behcet’ s disease in Korea and revealed the female predomi-
nance, higher frequency of ocular lesions, and lower positivity of pathergy test in
the patients.
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PATIENTS & METHODS 
The multicenter study was performed retrospectively with
the current data from January 1997 to December 1999.
Twenty-four departments from twenty hospitals in Korea
participated to this survey. Typical major features including
recurrent oral ulcer, skin lesions, eye lesions, and genital ulcers
were evaluated in the patients. The patients with four major
features diagnosed as complete type, the patients with three
major features, two major plus two minor features or typical
ocular symptom plus one major or two minor features diag-
nosed as incomplete type, and the patients with two major
features or one major plus two minor diagnosed as suspect-
ed type according to the revised Shimizu’ s classification (5).
A total of 3,497 patients who visited the hospitals in the
period were included as having Beh et’ s disease and were
checked by the following inquiry from the hospital records:
patient’ s name, date of birth, sex, geographic distribution,
clinical manifestations, durations of the symptoms, and pos-
itivity to pathergy test. Durations of symptoms were deter-
mined as the period from the beginning of at least one of
the diagnostic symptom criteria to the patient’ s first visit.
Geographic distribution was based on the location where the
symptom first occurred. Of 3,497 patients, 1,527 fulfilled
the Diagnostic Criteria of International Study Group for
Beh et’ s disease (6) and/or the revised Shimizu’ s classifica-
tion (5).
Pathergy test was performed with oblique insertion of 26
gauge needle under sterile condition and read by a physician
at 24 hr. Formation of papule or pustule was interpreted as
a positive result.
Statistical analysis was performed using SPSS version 9.0
(SPSS Inc. Chicago, U.S.A.). Kolmogorov-Smirnov test was
applied to evaluate the normality of the age and sex distri-
bution. Chi-square test was applied for comparing the sex
difference of pathergy test. Mann-Whitney test was applied
to evaluate the age distributions of onset and diagnosis of
the disease between males and females. A value of p<0.05
was regarded as statistically significant.
RESULTS
Of 3,497 patients, 1,527 were classified as complete or
incomplete type of Beh et’ s disease. According to the Shi-
mizu’ s classification, incomplete type was the most frequent
type (32.8%), followed by suspected type (32.3%), possible
type (24.0%) and complete type (10.9%), in order of decreas-
At the first visit Age of onset
Age (yr)
Female Male Total (%) Male Female Total (%)
Under 9 0 1 1 (0.07) 5 8 13 (0.85)
10-19 5 8 13 (0.85) 45 79 124 (8.12)
20-29 48 104 152 (9.95) 139 262 401 (26.26)
30-39 181 280 461 (30.19) 217 398 615 (40.28)
40-49 230 396 626 (41.0) 107 161 268 (17.55)
50-59 63 138 201 (13.16) 35 53 88 (5.76)
60-69 28 39 67 (4.39) 8 8 16 (1.05)
Over 70 1 5 6 (0.39) 0 2 2 (0.13)
Total 556 971 1,527 (100) 556 971 1,527 (100)
Table 2. Age and sex distributions of 1,527 patients with Beh et’ s disease
Classification Number of patients %
Complete 382 10.9
Incomplete 1,145 32.8
Suspected 1,130 32.3
Possible 840 24.0
Table 1. Classification of 3,497 patients with Beh et’ s disease
according to the Shimizu’ s criteria
Fig. 1. Geographical distribution of 1,527 patients with Beh et’ s
disease in Korea.
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ing frequency (Table 1). 
Table 2 summarizes age and sex distributions of the data.
The median age of onset was 33 yr (range 1-75) and the medi-
an age of diagnosis was 41 yr (range 5-75). The male to female
ratio was 1:1.75, indicating female predominance. The age
of onset was most commonly in their thirties, followed by
twenties (26.3%), forties (17.6%), and teens (8.1%). The
age at diagnosis was most commonly in the forties (41%).
There was no differences in the age distributions of onset
(p=0.444) and diagnosis (p=0.453) of the disease between
males and females. 
Geographical distribution showed that 38.5% of total
patients with Beh et’ s disease was in Seoul with the highest
frequency (Fig. 1). The order of frequencies of geographical
distribution was Kyonggido (27.9%), Kyongsangbukdo
(11.7%), Kyongsangnamdo (7.7%), Chollanamdo (4.1%),
Chungchongnamdo (3.3%), Chollabukdo (3.0%), Kang-
wondo (1.8%), Chungchongbukdo (1.7%) and Chejudo
(0.2%).
Major and minor clinical manifestations are summarized
in Table 3 and were oral ulcers (98.8%), skin lesions (84.3%),
genital ulcers (83.2%), ocular lesions (50.9%), articular symp-
toms (38.4%), gastrointestinal symptoms (7.3%), neurolog-
ic symptoms (4.6%), vascular symptoms (1.8%), and epi-
didymitis (0.6%), in order of decreasing frequency. The lon-
gest mean duration of clinical manifestation was 7 yr and 9
months with oral ulcer. 
The results of pathergy test were available in 715 patients
with Beh et’ s disease and showed positive in 110 patients
(15.4%) and revealed higher positive rates in males (20.2%)
than in females (12.7%) (p=0.008) (Table 4). 
DISCUSSION
The prevalence of Beh et’ s disease is known to be high in
Japan, China, Turkey, Tunisia, and the Mediterranean and
the Middle Eastern countries. The prevalence of Beh et’ s
disease in Korea also has been reported as high as the coun-
tries mentioned above. However, Beh et’ s disease is rarly
seen in the Northern Europe or in the United States.
The frequency of Beh et’ s disease in this study demon-
strated similar results with the previous report in 1997 per-
formed by Bang et al. with the results as follows (2): com-
plete type 16.1%, incomplete type 38.2%, suspected type
25.4%, and possible type 20.3%.
The result of sexual distribution in our studies was 1:1.75
with the female predominance, which is in line with the
previous study. However, in contrast to those studies, Zouboulis
et al. (7) reported the male predominance in classical Japanese
and Turkish patients with Beh et’ s disease and yet, there is
gradual increase of female patients, which leads to more of
1:1 male-to-female ratio. Saylan et al. (8) also noted the male
predominance in almost all middle eastern countries such as
Turkey, Iran, Lebanon, Iraq, Jordan, Israel, and Egypt. The
countries with the female predominance are Korea, China,
the United States and Britain. The difference in sexual dis-
tribution among the countries indicates some potential envi-
ronmental and genetic influences on the pathogenesis of the
disease. 
The age of onset and the age at diagnosis of Beh et’ s dis-
ease in the present study were slightly older than those in
the previous studies. The proprtion of group with the age of
onset under 20 was 8.97%, indicating the rarity of Beh et’ s
disease in young ages. 
The geographical distribution revealed higher proportion
in Seoul and Kyonggido. This result may be due to the dif-
ferences in the accessibility to the hospitals and population
density according to the region. The reports in Japan exhib-
ited a higher prevalence in northern area than southern Japan
(9). Nonetheless, our study could not determine distribu-
tional differences by the north versus south or by east versus
west. 
As in other studies, the positive rates of major symptoms
revealed that the most frequent major symptom was oral
ulcers. As for the minor clinical manifestations, articular
symptoms were most frequent. Moreover, the positive rate
of ocular lesions in the present study was much higher than
that in the previous studies in Korea. The increase in fre-
quency of ocular lesions may be due to the increase in rou-
tine tests for the eyes since the ocular lesions are considered
to be one of the most important prognostic factors. Further-
more, the exclusion of the possible type in this study might
have contributed to the higher frequency of ocular and artic-
ular symptoms.
Sex
Number of patients
Positive (%) Negative (%)
Male (n=257) 52 (20.2) 205 (79.8)
Female (n=458) 58 (12.7) 400 (87.3)
Total (%) 110 (15.4) 605 (84.6)
Table 4. Result of pathergy test in 715 patients with Beh et’ s
disease
Symptoms
Number of patients
(%)
Mean duration
(months)
Oral ulcers 1,508 (98.8) 93.3
Genital ulcers 1,271 (83.2) 53.8
Skin lesions 1,288 (84.3) 52.9
Ocular lesions 777 (50.9) 42.6
Articular symptoms 586 (38.4) 53.6
Gastrointestinal symptoms 111 (7.3) 58.5
Epididymitis 9 (0.6) 49.7
Vascular symptoms 27 (1.8) 51.4
Neurologic symptoms 70 (4.6) 41.5
Table 3. Major and minor symptoms of 1,527 patients with
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The positivity of the pathergy test in the present study
(15.4%) was significantly lower than that of Japan (43.8%)
and China (62.2%) (4, 10). This observation may be attribut-
ed to the differences in the method of pathergy test or to the
racial differences. The positivity of pathergy test is especial-
ly high in the Middle Eastern countries, which made the
test as a crucial parameter of diagnosis of Beh et’ s disease.
In contrast, the low positive rate of pathergy test in the pre-
sent study suggests a limitation of its use as a diagnostic
criteria in Korea. Yazici et al. (11) reported a higher positive
rate of pathergy test in males, which was also observed in
the present study.
In conclusion, we performed the first multicenter study
on Beh et’ s disease in Korea and revealed that the female
predominance, higher positive rate of ocular lesions and
lower positivity of pathergy test were the significant features
in Korean patients. Thus, the necessity of close observations
on the eyes and further investigation of prevalences through
the central registration system should be emphasized.
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